Old Web
English
Sign In
Acemap
>
authorDetail
>
De Jong Marion
De Jong Marion
Medicine
Octreotate
Cancer research
Alpha (ethology)
Pathology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The next step in increasing the efficacy of PRRT: Preclinical studies in vicvo and in vitro with 213Bi-[DOTA0,Tyr3]-octreotate
2015
Chan Ho Sze
Konijnenberg M.w.
De Blois Erik
Koelewijn S.j.
Anderson Tamara
Nysus Monique
Breeman W.a.p.
Atcher Robert
Morgenstern Alfred
Bruchertseifer Frank
Norenberg Jeffrey
De Jong Marion
Show All
Source
Cite
Save
Citations (0)
Targeted Alpha Radionuclide Therapy of Prostate Cancer Using a Small Molecule Inhibitor of Prostate-specific Membrane Antigen (PSMA)
2015
Chatalic K.l.s.
Heskamp Sandra
Nonnekens J
Molkenboer-Kuenen J.d.m.
Van Gent D
Bruchertseifer Frank
Morgenstern Alfred
M Weineisen
Wester Hans-Jürgen
Van Weerden W.m.
Boerman Otto
De Jong Marion
Show All
Source
Cite
Save
Citations (0)
Influence of tumour size on targeted alpha therapy with 213Bi-[DOTA,Tyr3]octreotate (DOTA-TATE) in a small cell lung carcinoma (SCLC) mouse model.
2014
Chan Ho Sze
Konijnenberg M.w.
De Blois Erik
Koelewijn S.j.
Morgenstern Alfred
Bruchertseifer Frank
Breeman Wouter
De Jong Marion
Show All
Source
Cite
Save
Citations (0)
High Resolution microSPECT imaging of Bi-213
2013
de Swart J
Segbers M
Morgenstern Alfred
Van Der Have F
Chan Ho Sze
Berndsen S.c.
Bruchertseifer Frank
De Jong Marion
Beekman F.j.
Konijnenberg M.w.
Show All
Source
Cite
Save
Citations (0)
1